Nomic Bio Revenue and Competitors

Location

$59M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nomic Bio's estimated annual revenue is currently $15.5M per year.(i)
  • Nomic Bio's estimated revenue per employee is $155,000
  • Nomic Bio's total funding is $59M.

Employee Data

  • Nomic Bio has 100 Employees.(i)
  • Nomic Bio grew their employee count by 67% last year.

Nomic Bio's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
Head AutomationReveal Email/Phone
4
Director Process DevelopmentReveal Email/Phone
5
Sr. Technical Sales ManagerReveal Email/Phone
6
Technical Product ManagerReveal Email/Phone
7
Technical Sales ManagerReveal Email/Phone
8
Customer Success Operations ManagerReveal Email/Phone
9
Senior Field Applications ScientistReveal Email/Phone
10
Associé opérations (Profiling)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.9M2213%$150.5MN/A
#2
$34.6M223-56%N/AN/A
#3
$1.9M1220%N/AN/A
#4
$4M26-7%N/AN/A
#5
$67.9M4381%N/AN/A
#6
$10.9M700%N/AN/A
#7
$10.9M700%N/AN/A
#8
$27M174-22%N/AN/A
#9
$5.1M3314%N/AN/A
#10
$3.9M5016%$65MN/A
Add Company

What Is Nomic Bio?

Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.

keywords:N/A

$59M

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11M10020%N/A
#2
$21M10072%N/A
#3
$20.5M10035%N/A
#4
$20.4M100-21%N/A
#5
$7.5M10041%N/A